Zimmer Biomet Holdings, Inc. (BIT:1ZBH)
Italy
· Delayed Price · Currency is EUR 79.36
-6.28 (-7.33%)
At close: Mar 5, 2026
Zimmer Biomet Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 8,232 | 7,679 | 7,394 | 6,940 | 6,827 | Upgrade
|
| Revenue Growth (YoY) | 7.20% | 3.85% | 6.55% | 1.65% | 11.42% | Upgrade
|
| Cost of Revenue | 2,494 | 2,180 | 2,076 | 2,020 | 1,960 | Upgrade
|
| Gross Profit | 5,738 | 5,499 | 5,319 | 4,920 | 4,867 | Upgrade
|
| Selling, General & Admin | 3,212 | 2,876 | 2,793 | 2,668 | 2,626 | Upgrade
|
| Research & Development | 458.5 | 437.4 | 458.7 | 406 | 435.8 | Upgrade
|
| Amortization of Goodwill & Intangibles | 665.9 | 591.9 | 561.5 | 526.8 | 529.5 | Upgrade
|
| Other Operating Expenses | - | - | - | 33.8 | 52.8 | Upgrade
|
| Operating Expenses | 4,336 | 3,905 | 3,813 | 3,634 | 3,645 | Upgrade
|
| Operating Income | 1,402 | 1,594 | 1,505 | 1,286 | 1,222 | Upgrade
|
| Interest Expense | -292.8 | -218 | -201.2 | -164.8 | -208.4 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.6 | -15.6 | -17.2 | -19.7 | -5.5 | Upgrade
|
| Other Non Operating Income (Expenses) | 29.2 | 3 | 2.2 | -0.5 | 1.7 | Upgrade
|
| EBT Excluding Unusual Items | 1,126 | 1,363 | 1,289 | 1,101 | 1,010 | Upgrade
|
| Merger & Restructuring Charges | -335.4 | -247 | -165.8 | -203 | -125.7 | Upgrade
|
| Impairment of Goodwill | - | - | - | -289.8 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.7 | -42.1 | -18.5 | -136 | - | Upgrade
|
| Legal Settlements | -22.7 | -30.5 | -21.6 | -65.9 | -201 | Upgrade
|
| Other Unusual Items | 77.1 | -7.1 | -16 | - | -168.2 | Upgrade
|
| Pretax Income | 830.7 | 1,037 | 1,067 | 403.5 | 499 | Upgrade
|
| Income Tax Expense | 125.7 | 131.4 | 42.2 | 112.3 | 53.5 | Upgrade
|
| Earnings From Continuing Operations | 705 | 905.3 | 1,025 | 291.2 | 445.5 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -58.8 | -43.4 | Upgrade
|
| Net Income to Company | 705 | 905.3 | 1,025 | 232.4 | 402.1 | Upgrade
|
| Minority Interest in Earnings | 0.1 | -1.5 | -1.1 | -1 | -0.5 | Upgrade
|
| Net Income | 705.1 | 903.8 | 1,024 | 231.4 | 401.6 | Upgrade
|
| Net Income to Common | 705.1 | 903.8 | 1,024 | 231.4 | 401.6 | Upgrade
|
| Net Income Growth | -21.98% | -11.74% | 342.52% | -42.38% | - | Upgrade
|
| Shares Outstanding (Basic) | 198 | 203 | 209 | 210 | 209 | Upgrade
|
| Shares Outstanding (Diluted) | 199 | 204 | 210 | 210 | 210 | Upgrade
|
| Shares Change (YoY) | -2.55% | -2.77% | -0.29% | -0.05% | 1.64% | Upgrade
|
| EPS (Basic) | 3.56 | 4.45 | 4.91 | 1.10 | 1.93 | Upgrade
|
| EPS (Diluted) | 3.55 | 4.43 | 4.88 | 1.10 | 1.91 | Upgrade
|
| EPS Growth | -19.86% | -9.22% | 343.48% | -42.50% | - | Upgrade
|
| Free Cash Flow | 1,172 | 1,055 | 978.8 | 838.5 | 1,082 | Upgrade
|
| Free Cash Flow Per Share | 5.90 | 5.18 | 4.67 | 3.99 | 5.14 | Upgrade
|
| Dividend Per Share | 0.960 | 0.960 | 0.960 | 0.960 | 0.960 | Upgrade
|
| Gross Margin | 69.71% | 71.61% | 71.93% | 70.90% | 71.29% | Upgrade
|
| Operating Margin | 17.03% | 20.76% | 20.36% | 18.53% | 17.90% | Upgrade
|
| Profit Margin | 8.57% | 11.77% | 13.85% | 3.33% | 5.88% | Upgrade
|
| Free Cash Flow Margin | 14.24% | 13.74% | 13.24% | 12.08% | 15.85% | Upgrade
|
| EBITDA | 2,495 | 2,590 | 2,457 | 2,213 | 2,160 | Upgrade
|
| EBITDA Margin | 30.31% | 33.73% | 33.23% | 31.88% | 31.64% | Upgrade
|
| D&A For EBITDA | 1,094 | 996.3 | 951.7 | 926.4 | 937.7 | Upgrade
|
| EBIT | 1,402 | 1,594 | 1,505 | 1,286 | 1,222 | Upgrade
|
| EBIT Margin | 17.03% | 20.76% | 20.36% | 18.53% | 17.90% | Upgrade
|
| Effective Tax Rate | 15.13% | 12.68% | 3.95% | 27.83% | 10.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.